Cronos Group Inc. - Common Share (CRON) News
Filter CRON News Items
CRON News Results
|Loading, please wait...|
CRON News Highlights
- For CRON, its 30 day story count is now at 12.
- Over the past 26 days, the trend for CRON's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about CRON are III, AB and CALT.
Latest CRON News From Around the Web
Below are the latest news stories about CRONOS GROUP INC that investors may wish to consider to help them evaluate CRON as an investment opportunity.
These are the overlooked cannabis stocks to buy at attractive levels as they represent companies poised for accelerated growth.
Calliditas Therapeutics AB Sponsored ADR (CALT) Surges 16.1%: Is This an Indication of Further Gains?
Calliditas Therapeutics AB Sponsored ADR (CALT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
These are the undervalued penny stocks to buy for 100% returns in a short period of time.
Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as resceduling approaches for weed.
TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with Cansativa Group (“Cansativa”), one of the leading distributors of medical cannabis in Germany. Cansativa is a market leader in the medical cannabis market and is a driving force in the German cannabis
Ultra-high yield stocks require greater due diligence by investors but these three stocks can offer greater rewards.
These are the small-cap stocks to buy and hold for multibagger returns
Cannabis stocks have become quite the hot item on the stock exchange lately, a trend that stretched into Monday's trading. Canadian weed companies also landed well in positive territory, with Organigram (NASDAQ: OGI) advancing at an 18% clip and Cronos Group (NASDAQ: CRON) rising by 9%. It's no accident that these rises came just before the influential rules committee of the U.S. House of Representatives is set to meet on an appropriations bill.
Dive into the burgeoning world of medical cannabis, by wagering on these three top medical cannabis stocks, poised for a massive leap by 2030.
The DEA is considering loosening its restrictions on marijuana.